RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$855M
AUM Growth
+$855M
(+32%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
16.99%
Top 10 Holdings %
Top 10 Hldgs %
33.51%
Holding
104
New
21
Increased
54
Reduced
10
Closed
11
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$9.57M |
| 4 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$9.5M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$8.91M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$13.2M |
| 2 |
Gilead Sciences
GILD
|
$10.2M |
| 3 |
Pacira BioSciences
PCRX
|
$9.89M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$8.92M |
| 5 |
Cardinal Health
CAH
|
$6.91M |
Sector Composition
| 1 | Healthcare | 73.14% |
| 2 | Financials | 1.36% |
| 3 | Technology | 0.94% |
| 4 | Industrials | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuitive Surgical
ISRG
$157B
| $9.79M | 1.14% |
18,500
| – | – |
|
|
SRGA
27
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $9.67M | 1.13% |
1,860,000
+400
| +0% | +$2.08K |
|
|
28
Health Care Select Sector SPDR Fund
XLV
$33.7B
| $9.57M | 1.12% |
+140,000
| New | +$9.57M |
|
29
Cigna
CI
$80.2B
| $9.57M | 1.12% |
93,000
+18,000
| +24% | +$1.85M |
|
|
TRNX
30
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $9.5M | 1.11% |
+372,500
| New | +$9.5M |
|
31
Bausch Health
BHC
$2.72B
| $9.05M | 1.06% |
63,250
+7,250
| +13% | +$1.04M |
|
32
Danaher
DHR
$143B
| $9.04M | 1.06% |
105,500
+20,500
| +24% | +$1.76M |
|
|
SLXP
33
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $8.91M | 1.04% |
+77,500
| New | +$8.91M |
|
|
HTWR
34
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $8.81M | 1.03% |
120,000
+38,000
| +46% | +$2.79M |
|
|
CBST
35
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $8.81M | 1.03% |
87,500
+41,000
| +88% | +$4.13M |
|
36
Cooper Companies
COO
$13.3B
| $8.75M | 1.02% |
54,000
-14,750
| -21% | -$2.39M |
|
37
Incyte
INCY
$16.9B
| $8.26M | 0.97% |
113,000
+10,000
| +10% | +$731K |
|
38
Neurocrine Biosciences
NBIX
$13.5B
| $8.04M | 0.94% |
360,000
+45,000
| +14% | +$1.01M |
|
|
RCPT
39
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $7.96M | 0.93% |
65,000
+42,500
| +189% | +$5.21M |
|
|
JUNO
40
DELISTED
Juno Therapeutics, Inc.
JUNO
| $7.54M | 0.88% |
+144,426
| New | +$7.54M |
|
41
Vertex Pharmaceuticals
VRTX
$101B
| $7.48M | 0.88% |
63,000
+5,500
| +10% | +$653K |
|
42
Cencora
COR
$57.1B
| $7.21M | 0.84% |
+80,000
| New | +$7.21M |
|
43
Perrigo
PRGO
$3.22B
| $7.1M | 0.83% |
42,500
+14,000
| +49% | +$2.34M |
|
|
TSRO
44
DELISTED
TESARO, Inc.
TSRO
| $6.97M | 0.82% |
187,500
+10,000
| +6% | +$372K |
|
|
PRAH
45
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.9M | 0.81% |
+285,000
| New | +$6.9M |
|
|
RAD
46
DELISTED
Rite Aid Corporation
RAD
| $6.9M | 0.81% |
917,300
+3,000
| +0.3% | +$22.6K |
|
|
MDCO
47
DELISTED
Medicines Co
MDCO
| $6.82M | 0.8% |
246,300
+98,050
| +66% | +$2.71M |
|
|
MWIV
48
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $6.63M | 0.78% |
39,000
| – | – |
|
|
KITE
49
DELISTED
Kite Pharma, Inc.
KITE
| $6.6M | 0.77% |
114,474
+32,000
| +39% | +$1.85M |
|
|
SRCL
50
DELISTED
Stericycle Inc
SRCL
| $6.55M | 0.77% |
50,000
+3,000
| +6% | +$393K |
|